litlas
ログインアカウント作成

Mark H. Pollack

1989–2025 年に発表

119
論文数
18,991
被引用数
87
h 指数
118
i10 指数

被引用数

Mark H. Pollack の年別被引用数1952 年: 被引用 2 件1955 年: 被引用 1 件1991 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 9 件1995 年: 被引用 9 件1996 年: 被引用 7 件1997 年: 被引用 10 件1998 年: 被引用 16 件1999 年: 被引用 18 件2000 年: 被引用 39 件2001 年: 被引用 40 件2002 年: 被引用 62 件2003 年: 被引用 46 件2004 年: 被引用 85 件2005 年: 被引用 110 件2006 年: 被引用 123 件2007 年: 被引用 161 件2008 年: 被引用 201 件2009 年: 被引用 173 件2010 年: 被引用 184 件2011 年: 被引用 178 件2012 年: 被引用 175 件2013 年: 被引用 198 件2014 年: 被引用 226 件2015 年: 被引用 192 件2016 年: 被引用 173 件2017 年: 被引用 132 件2018 年: 被引用 144 件2019 年: 被引用 339 件2020 年: 被引用 402 件2021 年: 被引用 271 件2022 年: 被引用 245 件2023 年: 被引用 144 件2024 年: 被引用 222 件2025 年: 被引用 99 件2026 年: 被引用 1 件1953〜1954 年は被引用が無いため表示していません1956〜1990 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,979 件、この内訳の 37.6%イギリス: 引用元論文 414 件、この内訳の 7.9%ドイツ: 引用元論文 297 件、この内訳の 5.6%カナダ: 引用元論文 279 件、この内訳の 5.3%イタリア: 引用元論文 216 件、この内訳の 4.1%オーストラリア: 引用元論文 192 件、この内訳の 3.6%中国: 引用元論文 184 件、この内訳の 3.5%オランダ: 引用元論文 157 件、この内訳の 3%ブラジル: 引用元論文 117 件、この内訳の 2.2%スイス: 引用元論文 105 件、この内訳の 2%スペイン: 引用元論文 105 件、この内訳の 2%フランス: 引用元論文 103 件、この内訳の 2%
0%37.6%その他 21.2%

機関

分野

  • Psychology34.4%
  • Medicine33%
  • Neuroscience24.7%
  • Biochemistry, Genetics and Molecular Biology3.3%
  • Computer Science1.1%
  • Health Professions0.9%
  • その他2.6%

トピック

  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes6.5%
  • Treatment of Major Depression4.6%
  • Tryptophan and brain disorders4.5%
  • Stress Responses and Cortisol4.4%
  • Bipolar Disorder and Treatment3.4%
  • Child and Adolescent Psychosocial and Emotional Development2.6%
  • その他74%

共著者

全論文

検索で開く
  1. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders

    著者: Mark S. George, Herbert E. Ward, Philip T. Ninan, Mark H. Pollack, Ziad Nahas, Berry Anderson, Samet Köse, Robert H. Howland, Wayne K. Goodman, James C. Ballenger - Brain stimulation 2008 被引用: 251

  2. Brain connectomics predict response to treatment in social anxiety disorder

    著者: Susan Whitfield‐Gabrieli, Satrajit Ghosh, Alfonso Nieto-Castañón, Zeynep M. Saygin, Oliver Doehrmann, Xiaoqian J. Chai, Gretchen Reynolds, Stefan G. Hofmann, Mark H. Pollack, John D. E. Gabrieli - Molecular Psychiatry 2015 被引用: 216

  3. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)

    著者: Gregory M. Chandler, Dan V. Iosifescu, Mark H. Pollack, Steven D. Targum, Maurizio Fava - CNS Neuroscience & Therapeutics 2009 被引用: 156

  4. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A)

    著者: M. Katherine Shear, Joni Vander Bilt, Paola Rucci, Jean Endicott, Bruce Lydiard, Michael W. Otto, Mark H. Pollack, L.P. Chandler, Jenna Williams, Arjumand Ali, David M. Frank - Depression and Anxiety 2001 被引用: 478

  5. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders

    著者: David Mataix‐Cols, Lorena Fernández de la Cruz, Benedetta Monzani, David Rosenfield, Erik Andersson, Ana Pérez-Vigil, Paolo Frumento, Rianne A. de Kleine, JoAnn Difede, Boadie W. Dunlop, Lara J. Farrell, Daniel Geller, Maryrose Gerardi, Adam J. Guastella, Stefan G. Hofmann, Gert‐Jan Hendriks, Matt G. Kushner, Francis S. Lee, Eric J. Lenze, Cheri A. Levinson, Harry McConnell, Michael W. Otto, Jens Plag, Mark H. Pollack, Kerry J. Ressler, Thomas L. Rodebaugh, Barbara O. Rothbaum, Michael S. Scheeringa, Anja Siewert-Siegmund, Jasper A. J. Smits, Eric A. Storch, Andreas Ströhle, Candyce D. Tart, David F. Tolin, Agnes van Minnen, Allison M. Waters, Carl F. Weems, Sabine Wilhelm, Katarzyna Wyka, Michael Davis, Christian Rück, Margaret Altemus, Page L. Anderson, Judith Cukor, Claudia Finck, Gary R. Geffken, Fabian Golfels, Wayne K. Goodman, Cassidy A. Gutner, Isobel Heyman, Tanja Jovanović, Adam B. Lewin, Joseph P. H. McNamara, Tanya K. Murphy, Seth D. Norrholm, Paul Thuras - JAMA Psychiatry 2017 被引用: 292

  6. Randomized Controlled Trial of Mindfulness Meditation for Generalized Anxiety Disorder

    著者: Elizabeth A. Hoge, Éric Bui, Luana Marques, Christina A. Metcalf, Laura K. Morris, Donald J. Robinaugh, John J. Worthington, Mark H. Pollack, Naomi M. Simon - The Journal of Clinical Psychiatry 2013 被引用: 510

  7. Comorbid anxiety and depression.

    著者: Mark H. Pollack - 2005 被引用: 221

  8. Abnormal intestinal milieu in posttraumatic stress disorder is not impacted by treatment that improves symptoms

    著者: Robin M. Voigt, Alyson K. Zalta, Shohreh Raeisi, Lijuan Zhang, J. Mark Brown, Christopher B. Forsyth, Randy A. Boley, Philip Held, Mark H. Pollack, Ali Keshavarzian - American Journal of Physiology-Gastrointestinal and Liver Physiology 2022 被引用: 26

  9. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder

    著者: Elizabeth A. Hoge, K. Brandstetter, Samantha J. Moshier, Mark H. Pollack, Kwok‐Kin Wong, Naomi M. Simon - Depression and Anxiety 2009 被引用: 350

  10. The effect of mindfulness meditation training on biological acute stress responses in generalized anxiety disorder

    著者: Elizabeth A. Hoge, Éric Bui, Sophie A. Palitz, Noah Schwarz, Maryann E. Owens, Jennifer M. Johnston, Mark H. Pollack, Naomi M. Simon - Psychiatry Research 2017 被引用: 196

  11. Eszopiclone Coadministered With Escitalopram in Patients With Insomnia and Comorbid Generalized Anxiety Disorder

    著者: Mark H. Pollack, Gustavo Kinrys, Andrew D. Krystal, W. Vaughn McCall, Thomas Roth, Kendyl Schaefer, Robert Rubens, James Roach, Holly Huang, Ranga Krishnan - Archives of General Psychiatry 2008 被引用: 158

  12. Placebo-Controlled Study of Gabapentin Treatment of Panic Disorder

    著者: Atul C. Pande, Mark H. Pollack, Jerri G. Crockatt, Martha Greiner, Guy Chouinard, R. Bruce Lydiard, C. Barr Taylor, Stephen R. Dager, Thomas Shiovitz - Journal of Clinical Psychopharmacology 2000 被引用: 281

  13. Predicting Treatment Response in Social Anxiety Disorder From Functional Magnetic Resonance Imaging

    著者: Oliver Doehrmann, Satrajit Ghosh, Frida E. Polli, Gretchen Reynolds, Franziska Horn, Anisha Keshavan, Christina Triantafyllou, Zeynep M. Saygin, Susan Whitfield‐Gabrieli, Stefan G. Hofmann, Mark H. Pollack, John D. E. Gabrieli - JAMA Psychiatry 2012 被引用: 265

  14. Oxytocin Levels in Social Anxiety Disorder

    著者: Elizabeth A. Hoge, Mark H. Pollack, Rebecca E. Kaufman, Paul J. Zak, Naomi M. Simon - CNS Neuroscience & Therapeutics 2008 被引用: 216

  15. Anxiety Disorder Comorbidity in Bipolar Disorder Patients: Data From the First 500 Participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

    著者: Naomi M. Simon, Michael W. Otto, Stephen R. Wisniewski, Mark D. Fossey, Kemal Sagduyu, Ellen Frank, Gary S. Sachs, Andrew A. Nierenberg, Michael E. Thase, Mark H. Pollack, for the STEP-BD Investigators - American Journal of Psychiatry 2004 被引用: 561

  16. Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis.

    著者: Robert A. Gould, Susan Buckminster, Mark H. Pollack, Michael W. Otto, Liang Yap - Clinical Psychology Science and Practice 1997 被引用: 444

  17. Resilience: research evidence and conceptual considerations for posttraumatic stress disorder

    著者: Elizabeth A. Hoge, Eloise D. Austin, Mark H. Pollack - Depression and Anxiety 2006 被引用: 328

  18. A detailed examination of cytokine abnormalities in Major Depressive Disorder

    著者: Naomi M. Simon, Kate McNamara, Candice Chow, Richard S. Maser, George I. Papakostas, Mark H. Pollack, Andrew A. Nierenberg, Maurizio Fava, Kwok‐Kin Wong - European Neuropsychopharmacology 2007 被引用: 287

  19. Pregabalin for Treatment of Generalized Anxiety Disorder

    著者: Karl Rickels, Mark H. Pollack, Douglas E. Feltner, R. Bruce Lydiard, Daniel L. Zimbroff, Robert J. Bielski, Kathy Tobias, Jerri Brock, Gwen L. Zornberg, Atul C. Pande - Archives of General Psychiatry 2005 被引用: 281

  20. Paroxetine CR Augmentation for Posttraumatic Stress Disorder Refractory to Prolonged Exposure Therapy

    著者: Naomi M. Simon, Kathryn M. Connor, Ariel J. Lang, Sheila A. M. Rauch, Stan Krulewicz, Richard T. LeBeau, Jonathan Davidson, Murray B. Stein, Michael W. Otto, Edna B. Foa, Mark H. Pollack - The Journal of Clinical Psychiatry 2008 被引用: 126

  21. CORTICO-LIMBIC RESPONSES TO MASKED AFFECTIVE FACES ACROSS PTSD, PANIC DISORDER, AND SPECIFIC PHOBIA

    著者: William D. S. Killgore, Jennifer C. Britton, Zachary J. Schwab, Lauren M. Price, Melissa R. Weiner, Andrea L. Gold, Isabelle M. Rosso, Naomi M. Simon, Mark H. Pollack, Scott L. Rauch - Depression and Anxiety 2013 被引用: 119

  22. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam

    著者: Mark H. Pollack, J. Eric Jensen, Naomi M. Simon, Rebecca E. Kaufman, Perry F. Renshaw - Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 被引用: 114

  23. Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder

    著者: Stefan G. Hofmann, Alicia E. Meuret, Jasper A. J. Smits, Naomi M. Simon, Mark H. Pollack, Katherine Eisenmenger, Michael Shiekh, Michael W. Otto - Archives of General Psychiatry 2006 被引用: 566

  24. Telomere Shortening and Mood Disorders: Preliminary Support for a Chronic Stress Model of Accelerated Aging

    著者: Naomi M. Simon, Jordan W. Smoller, Kate L. McNamara, Richard S. Maser, Alyson K. Zalta, Mark H. Pollack, Andrew A. Nierenberg, Maurizio Fava, Kwok‐Kin Wong - Biological Psychiatry 2006 被引用: 516